J. L. Mesías Iglesias

Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2011 · 1K citations · Full text

Weekly <i>nab</i>-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Mark A. Socinski, Igor Bondarenko, Nina Karaseva et al. · Journal of Clinical Oncology · 2012 · 745 citations · Full text

Purification and Properties of a <scp>d</scp>‐Galactose/<i>N</i>‐Acetyl‐<scp>d</scp>‐ galactosamine‐Specific Lectin from <i>Erythrina cristagalli</i>

J. L. Mesías Iglesias, Halina Lis, Nathan Sharon · European Journal of Biochemistry · 1982 · 178 citations

Bioorganic Chemistry, Engineering, Glycobiology +20

Randomized phase III study of weekly <i>nab</i>-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT).

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · Journal of Clinical Oncology · 2013 · 116 citations

Chemoprevention Strategy, Oncology, Pancreatic Cancer +18

Immunochemical studies on the combining site of the d-galactose/N-acetyl-d-galactosamine specific lectin from Erythrina cristagalli seeds

Paul M. Kaladas, Elvin A. Kabat, J. L. Mesías Iglesias et al. · Archives of Biochemistry and Biophysics · 1982 · 73 citations

Immunochemical Studies, Engineering, Allergy +10